Patrick Burch

844 total citations
13 papers, 653 citations indexed

About

Patrick Burch is a scholar working on Oncology, Molecular Biology and Nature and Landscape Conservation. According to data from OpenAlex, Patrick Burch has authored 13 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Nature and Landscape Conservation. Recurrent topics in Patrick Burch's work include Seedling growth and survival studies (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer therapeutics and mechanisms (2 papers). Patrick Burch is often cited by papers focused on Seedling growth and survival studies (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer therapeutics and mechanisms (2 papers). Patrick Burch collaborates with scholars based in United States. Patrick Burch's co-authors include Shepard M. Zedaker, Frank H. Valone, Dennis A. Gastineau, Ronald L. Richardson, Stanimir Vuk‐Pavlović, Henry C. Pitot, Jan C. Buckner, Judith S. Kaur, Jelle W. Kylstra and Gary A. Croghan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Patrick Burch

13 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Burch United States 8 318 307 249 174 67 13 653
Stefan Birrer Switzerland 10 201 0.6× 112 0.4× 66 0.3× 142 0.8× 246 3.7× 14 544
Maud Charpentier United States 11 260 0.8× 249 0.8× 337 1.4× 62 0.4× 19 0.3× 19 635
Peter C. Möller United States 18 161 0.5× 348 1.1× 526 2.1× 100 0.6× 81 1.2× 45 999
Frida Rosengren Sweden 10 404 1.3× 201 0.7× 248 1.0× 156 0.9× 22 0.3× 22 661
Janice Kielbassa France 11 161 0.5× 156 0.5× 225 0.9× 51 0.3× 20 0.3× 14 518
Josane F. Sousa Brazil 16 256 0.8× 211 0.7× 466 1.9× 120 0.7× 280 4.2× 28 955
Leslee Sprague United States 14 95 0.3× 301 1.0× 194 0.8× 35 0.2× 46 0.7× 19 722
Diego Salas‐Benito Spain 11 357 1.1× 235 0.8× 120 0.5× 117 0.7× 60 0.9× 25 661
Soumaya El Rouby United States 11 281 0.9× 220 0.7× 293 1.2× 54 0.3× 31 0.5× 24 785
Ryoji Fujii Japan 14 85 0.3× 255 0.8× 242 1.0× 78 0.4× 150 2.2× 39 757

Countries citing papers authored by Patrick Burch

Since Specialization
Citations

This map shows the geographic impact of Patrick Burch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Burch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Burch more than expected).

Fields of papers citing papers by Patrick Burch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Burch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Burch. The network helps show where Patrick Burch may publish in the future.

Co-authorship network of co-authors of Patrick Burch

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Burch. A scholar is included among the top collaborators of Patrick Burch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Burch. Patrick Burch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chaiteerakij, Roongruedee, David B. Zhen, Patrick Burch, et al.. (2015). Abstract LB-183: Metformin use does not increase survival of pancreatic cancer patients: A cautionary lesson. Cancer Research. 75(15_Supplement). LB–183. 4 indexed citations
2.
McWilliams, Robert R., et al.. (2011). Genome-wide interaction study of gemcitabine treatment and genotype on survival in pancreatic cancer.. Journal of Clinical Oncology. 29(15_suppl). 4022–4022. 1 indexed citations
3.
Markovic, S. N., et al.. (2011). Adjuvant GM-CSF therapy for patients with resected stage III/IV melanoma: A retrospective review of a single-center experience.. Journal of Clinical Oncology. 29(15_suppl). 8596–8596. 3 indexed citations
4.
Burch, Patrick, Gary A. Croghan, Dennis A. Gastineau, et al.. (2004). Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen‐independent prostate cancer: A phase 2 trial. The Prostate. 60(3). 197–204. 156 indexed citations
5.
Berry, Donna L., Carol M. Moinpour, Chen Jiang, et al.. (2004). Quality of life (QOL) and pain in advanced stage prostate cancer: impact of missing data on evaluating palliation in SWOG 9916. Journal of Clinical Oncology. 22(14_suppl). 4579–4579. 1 indexed citations
6.
Burch, Patrick & Shepard M. Zedaker. (2003). Removing the Invasive TreeAilanthus altissimaand Restoring Natural Cover. Arboriculture & Urban Forestry. 29(1). 18–24. 66 indexed citations
7.
Alberts, Steven R., Charles Erlichman, Jeff A. Sloan, et al.. (2001). Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks. Annals of Oncology. 12(5). 627–631. 7 indexed citations
8.
Burch, Patrick, Jan C. Buckner, Dennis A. Gastineau, et al.. (2000). Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.. PubMed. 6(6). 2175–82. 222 indexed citations
9.
Pitot, Henry C., Richard M. Goldberg, Joel M. Reid, et al.. (2000). Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.. PubMed. 6(6). 2236–44. 65 indexed citations
10.
Buckner, Jan C., et al.. (1998). Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma. Journal of Neuro-Oncology. 36(1). 65–70. 11 indexed citations
11.
Burch, Patrick. (1998). Principles and Practice of Genitourinary Oncology. Mayo Clinic Proceedings. 73(2). 198–199. 95 indexed citations
12.
Burch, Patrick, et al.. (1996). Red Maple and Silver Maple Growth Evaluated 10 Years After Application of Paclobutrazoltree Growth Regulator. Arboriculture & Urban Forestry. 22(2). 61–66. 15 indexed citations
13.
Burch, Patrick, et al.. (1994). Growth, Biomass, and Trim/Chip Time Reduction Following Application of Flurprimidol Tree Growth Regulator. Arboriculture & Urban Forestry. 20(1). 38–45. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Birrer Breakdown of academic impact, for papers by Maud Charpentier Breakdown of academic impact, for papers by Peter C. Möller Breakdown of academic impact, for papers by Frida Rosengren Breakdown of academic impact, for papers by Janice Kielbassa Breakdown of academic impact, for papers by Josane F. Sousa Breakdown of academic impact, for papers by Leslee Sprague Breakdown of academic impact, for papers by Diego Salas‐Benito Breakdown of academic impact, for papers by Soumaya El Rouby Breakdown of academic impact, for papers by Ryoji Fujii
Rankless by CCL
2026